Combining motion performance with EEG for diagnosis of mild cognitive impairment: a new perspective
Xianglong Wan,Shulin Xing,Yifan Zhang,Dingna Duan,Tiange Liu,Danyang Li,Hao Yu,Dong Wen
DOI: https://doi.org/10.3389/fnins.2024.1476730
IF: 4.3
2024-12-05
Frontiers in Neuroscience
Abstract:The prevalence of mild cognitive impairment (MCI) is rapidly increasing with the growing global elderly population.Approximately 15% to 20% of individuals aged 65 and above suffer from MCI (Petersen et al., 2018). Nowadays, the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are commonly used scales for MCI detection (Nasreddine et al., 2005;Ciesielska et al., 2016). Except for the scales, the fluid biomarkers, such as plasma phospho-tau217 and total-tau in cerebrospinal fluid, can also be used for MCI detection (Olsson et al., 2016;Palmqvist et al., 2020;Moscoso et al., 2021). Even though the diagnosis of MCI based on these biomarkers demonstrates outstanding accuracy and stability, it is not without its limitations. Lumbar puncture stands as a frequently conducted invasive procedure in clinical practice, utilized for the extraction of cerebrospinal fluid samples (Doherty and Forbes, 2014). It requires a relatively long postoperative recovery time and may lead to complications, such as headache, cranial nerve palsy, and reversible tonsillar descent. (Evans, 1998).Although the main symptom of MCI is memory impairment, motor dysfunction has been previously described as a common characteristic in the patients with cognitive impairments (Montero-Odasso et al., 2014). In comparison to normal subjects, individuals with MCI exhibit differences in some motions, such as walking and balance. According to Shin et al. (2011); Rosenberg et al. (2023), motion performance indices extracted from them can be used for diagnosing MCI.However, as the physical activity is only weakly associated with the global cognition (Iso-Markku et al., 2024), motion performance tests could not be used to directly detect subtle alterations in the cognitive functions of MCI patients. To address the aforementioned issues, it is imperative to discover a novel approach to enhance both diagnostic efficiency and accuracy.We postulate on the combination of EEG and motion performance tests as a crucial tool for MCI diagnosis. The electroencephalogram (EEG) is a non-invasive electrophysiological monitoring technique used to monitor brain electrical activity, offering superior temporal resolution. Owing to distinctions in EEG features between individuals with MCI and the normal ones, such as power spectral density (PSD) and band power, EEG can be independently utilized in the diagnosis of MCI (Meghdadi et al., 2021;Mitsukura et al., 2022).The application of automated feature learning techniques (such as deep learning and machine learning) in MCI diagnosis enables EEG-based diagnostic methods to achieve high accuracy and AUC (Al-Nuaimi et al., 2018, 2021;Meghdadi et al., 2021). Therefore, combining motion with EEG for MCI diagnosis can compensate for the lack of accuracy and AUC when using motion alone to diagnose MCI (You et al., 2020). Moreover, although MCI patients can maintain relatively independent activities in daily life, they are often affected to varying degrees when performing tasks with high cognitive load (Jekel et al., 2015;Klotzbier and Schott, 2017). Mainstream EEG-based MCI diagnostics typically use resting-state EEG, which makes it difficult to assess which daily activities are affected in MCI patients. This study comprehensively reviews the literature on the MCI diagnosis with EEG and motion performance tests. In consideration of prior studies, we additionally delve into the combination of EEG and motion performance indices for diagnostic purposes, and propose our own opinions about the development trends of this diagnostic strategy. Finally, we propose recommendations to advance research in the diagnosis of MCI.Motion is governed by the brain and spinal cord nerves. The connection between motion, cognition, and the nervous system is closely intertwined (Gentsch et al., 2016). Extensive study indicates that many non-cognitive symptoms, such as motor function loss, major depression and disruptive behaviors, are associated with neurodegenerative diseases (Goldman et al., 1999;Lopez et al., 2005;Haaxma et al., 2010;Buchman and Bennett, 2011).In recent years, a plethora of study findings has shown that gait dysfunction is a prevalent characteristic among patients with MCI. As gait plays a crucial role in discriminating pathology and identifying the progression of the disease (Morris et al., 2016), gait parameter can serve as one of the motion performance indices for diagnosing MCI (Montero-Odasso et al., 2014). In this study, an electronic walkway was utilized to assess the gait performance of individuals with MCI as well as that of normal individuals. The participants carried out dual-tasks walking, and the coefficient of variation for stride time was recorded, respectively. It is a motor-divided attention task that requires individuals to walk while doing a cognitively demanding task (reciting words or calculations). The results indicated deficits in g -Abstract Truncated-
neurosciences